BRIEF published on 05/08/2026 at 14:21, 1 month 18 days ago Porsche Focuses on Core Business Amid Strategic Realignment Core Business Focus Market Changes Porsche Strategic Realignment Subsidiaries Discontinued Employee Impact
PRESS RELEASE published on 05/08/2026 at 14:16, 1 month 18 days ago Porsche sharpens focus on core business Dr. Ing. h.c. F. Porsche AG implements strategic realignment with the discontinuation of subsidiaries, affecting over 500 employees, to refocus on core business. CEO emphasizes the necessity of painful cuts for successful restructuring Porsche Strategic Realignment Core Business Subsidiaries Job Reductions
BRIEF published on 05/07/2026 at 17:20, 1 month 18 days ago Porsche Restructures Executive Board: Car IT Integrated into R&D Executive Board Research & Development Porsche Restructuring Car IT Integration Sajjad Khan
BRIEF published on 05/07/2026 at 17:20, 1 month 18 days ago Porsche restructure sa direction : l'informatique automobile est intégrée à la R&D Recherche Et Développement Conseil D'administration Sajjad Khan Restructuration De Porsche Intégration Informatique Automobile
PRESS RELEASE published on 05/07/2026 at 17:15, 1 month 19 days ago Porsche streamlines the Executive Board: Car IT to be part of Research & Development in the future Porsche AG restructures Executive Board, integrating Car IT into Research & Development. Sajjad Khan to lead software partnership model for enhanced user experience Executive Board Porsche AG Research & Development Sajjad Khan Car IT
BRIEF published on 04/29/2026 at 17:35, 1 month 26 days ago Porsche AG poursuit son recentrage stratégique malgré les difficultés économiques Défis Économiques Réalignement Stratégique Porsche AG Profit Automobile Stratégie 2035
BRIEF published on 04/29/2026 at 17:35, 1 month 26 days ago Porsche AG Continues Strategic Realignment Amid Economic Challenges Strategic Realignment Economic Challenges Porsche AG Strategy 2035 Automotive Profit
PRESS RELEASE published on 04/29/2026 at 17:30, 1 month 26 days ago Porsche AG resolutely pushes ahead with strategic realignment Porsche AG reports Q1 results, group profit of 595 million euros supporting full-year forecast. Focus on strategic realignment for leaner, faster production of sports cars Financial Forecast Strategic Realignment Q1 Results Porsche AG Sportscars
BRIEF published on 04/24/2026 at 10:05, 2 months 2 days ago Porsche Divests Stakes in Bugatti Rimac and Rimac Group Acquisition Porsche Bugatti Rimac Rimac Group HOF Capital
BRIEF published on 04/24/2026 at 10:05, 2 months 2 days ago Porsche cède ses participations dans Bugatti Rimac et Rimac Group Acquisition Porsche Bugatti Rimac HOF Capital Groupe Rimac
Published on 06/26/2026 at 14:05, 3 hours 13 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 3 hours 18 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 4 hours 18 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 4 hours 33 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 17:05, 13 minutes ago NAKIKI SE Receives an Adverse Opinion on Its 2024 Financial Statements and Management Report
Published on 06/26/2026 at 17:00, 18 minutes ago Darwin AG Announces Results of the 2026 Annual General Meeting
Published on 06/26/2026 at 15:30, 1 hour 47 minutes ago JMGO Extends Special Savings Beyond Prime Day with N3 Ultimate at Its Best Price Since Launch
Published on 06/26/2026 at 15:23, 1 hour 54 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/26/2026 at 07:00, 10 hours 18 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 10 hours 18 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
